Literature DB >> 11733286

Endonasal dacryocystorhinostomy: a report by the American Academy of Ophthalmology.

J J Woog, R H Kennedy, P L Custer, S A Kaltreider, D R Meyer, J G Camara.   

Abstract

OBJECTIVE: This document describes endonasal dacryocystorhinostomy (DCR) and examines the evidence to answer key questions about the effectiveness of the procedure compared with external DCR; the relative indications, contraindications, advantages, and limitations of the procedure; and patient selection, surgical technique, postoperative care, and complications.
METHODS: A literature search conducted for the years 1968 to 2000 retrieved 93 citations. The panel members reviewed 71 of these articles and selected 64 for the panel methodologist to review and rate according to the strength of evidence. A level I rating is assigned to properly conducted, well-designed, randomized clinical trials; a level II rating is assigned to well-designed cohort and case-control studies; and a level III rating is assigned to case series and poorly designed prospective and retrospective studies, including case-control studies.
RESULTS: The published literature includes two reports that describe clinical trials comparing endonasal with external DCR with a 1-year follow-up. The success rate was 91% for the external DCR group in both reports and 63% and 75% for the endonasal DCR groups, defined by patency to irrigation. A longitudinal cohort study included a control group of age-matched external DCR patients who were compared with a study group of endonasal DCR patients. The reported success rate at 9 months following surgery for the endonasal cohort was 90% and was not statistically significantly different from the 94% success rate noted in the external DCR control group. Remaining data on reported success rates of primary and revision endonasal DCR were obtained from a collection of uncontrolled observational case studies with varying periods of follow-up and success rates ranging from 59% to 100%.
CONCLUSIONS: It is difficult to make definite evidence-based determinations about the relative efficacy of endonasal and external DCR because of the deficiencies in the reported literature. Based on level III evidence, the available data suggest that endonasal DCR may be a viable option for the correction of acquired nasolacrimal duct obstruction and complex forms of congenital dacryostenosis in selected patients. This procedure may be indicated on a primary basis or as revisional surgery following failed external or endonasal DCR. Some studies comparing endonasal DCR with external DCR suggested lower success rates in the endonasal group; other studies yielded success rates comparable with or exceeding those of external surgery. Reported complications of endonasal DCR do not generally appear to be greater in frequency or magnitude than those associated with external DCR. Disadvantages of endonasal DCR include the preferred use of general anesthesia by many surgeons, the high cost of expensive equipment and instrumentation, and the relatively steep learning curve for this procedure. Depending on the preference of the surgeon, more postoperative care may be required for patients undergoing endonasal DCR than external DCR. Both the advantages and the limitations of endonasal DCR relative to external DCR should be carefully discussed with patients who are contemplating endonasal surgery.

Entities:  

Mesh:

Year:  2001        PMID: 11733286     DOI: 10.1016/s0161-6420(01)00945-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  42 in total

1.  Chronic inflammation: a poor prognostic factor for endoscopic dacryocystorhinostomy.

Authors:  Ozlem Ozer; Görkem Eskiizmir; Halis Unlü; Aydin Işisağ; Asim Aslan
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-11       Impact factor: 2.503

2.  Endoscopic dacryocystorhinostomy: personal experience.

Authors:  L Muscatello; M Giudice; G Spriano; L Tondini
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-08       Impact factor: 2.124

3.  Cannula dacryocystorhinostomy: a simple, innovative and cost-effective method of lacrimal surgery.

Authors:  Shreya M Shah; Mehul A Shah; Chintan Patel
Journal:  Int Ophthalmol       Date:  2013-12-20       Impact factor: 2.031

4.  Dacryocystorhinostomy: History, evolution and future directions.

Authors:  Vladimir S Yakopson; Joseph C Flanagan; Daniel Ahn; Betsy P Luo
Journal:  Saudi J Ophthalmol       Date:  2010-10-18

5.  Effects of ostium granulomas and intralesional steroid injections on the surgical outcome in endoscopic dacryocystorhinostomy.

Authors:  Aerin Jo; Shin-Hyo Lee; Wu-Chul Song; Hyun Jin Shin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-01       Impact factor: 3.117

6.  Safety and efficacy of adjunctive intranasal mitomycin C and triamcinolone in endonasal endoscopic dacryocystorhinostomy.

Authors:  Emmy Y Li; Andy C Cheng; Alex C Wong; Amy M Sze; Hunter K Yuen
Journal:  Int Ophthalmol       Date:  2015-05-26       Impact factor: 2.031

7.  Mechanical endonasal dacryocystorhinostomy with mucosal flaps.

Authors:  A Tsirbas; P J Wormald
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

8.  Paediatric endoscopic endonasal dacryocystorhinostomy in congenital nasolacrimal duct obstruction.

Authors:  Igal Leibovitch; Dinesh Selva; Angelo Tsirbas; Edward Greenrod; John Pater; Peter J Wormald
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

9.  A simple and evolutional approach proven to recanalise the nasolacrimal duct obstruction.

Authors:  D Chen; J Ge; L Wang; Q Gao; P Ma; N Li; D-Q Li; Z Wang
Journal:  Br J Ophthalmol       Date:  2009-05-04       Impact factor: 4.638

10.  Successful endonasal dacryocystorhinostomy in a patient with Wegener's granulomatosis.

Authors:  P Eloy; E Leruth; B Bertrand; P H Rombaux
Journal:  Clin Ophthalmol       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.